• HCV reinfection uncommon in injection drug users after treatment

    1 month ago - By Healio

    SAN FRANCISCO - Despite continued drug use, hepatitis C reinfection rarely occurred in a cohort of patients with HCV who received opioid agonist therapy and were treated for HCV, according to findings presented at The Liver Meeting 2018.
    Jason Grebely, PhD, of The Kirby Institute at the UNSW Sydney, Australia, and colleagues, aimed to further analyze HCV reinfection patterns as they associate with injection drug use risk behavior in a cohort of patients who completed the Co-STAR Part A study.
    “The Co-STAR Part B trial design was a 3-year observational study open to all participants
    Read more ...